Articles related to DIET & NUTRITION

Study Reveals Different Effects of Antipsychotics on Weight Gain: Key Findings for Physicians A new study analyzed the impact of different antipsychotic medications on weight gain, emphasizing the importance of considering dose and specific drugs for individual patients. The study provides valuable insights for physicians to make informed decisions regarding antipsychotic use. Key Points: “Weight gain from medication is one of the most problematic adverse effects facing patients with serious mental illness… It can be a real barrier in getting people to take their meds.” Michel Sabé, MD, corresponding author

Navigating the Interplay of Eliquis and Dietary Habits As physicians, understanding the nuances of apixaban (Eliquis) and its interaction with diet is crucial for optimal patient care. While taking Eliquis, there are no specific foods to avoid, but people with cardiovascular issues should steer clear of coffee and foods heavy in fat.

Decoding the Interplay of Fasting, mTOR, and Seizure Control This article illuminates the critical function of fasting and mTOR regulation in the treatment of epilepsy by delving into the intricate molecular processes.

Unveil the potential ramifications of a pro-inflammatory diet on MS patients, especially concerning relapse rate and inflammatory brain lesions. Recent research from the University of Tasmania offers key insights into diet and MS. Essentially, a pro-inflammatory diet may boost relapse rates and inflammatory brain lesions. This highlights the potential impact of such a diet on MS patients. Notably, this diet didn’t influence disability progression or chronic inflammation lesions. MS, defined as a chronic autoimmune disease, harms nerve cells. Significantly, lifestyle modifications may enhance MS symptoms and outcomes. A diet high in fats and proteins, known as a pro-inflammatory diet, could heighten inflammation. Conversely, incorporating anti-inflammatory foods like turmeric, fiber, and beta-carotene may benefit those with inflammatory diseases. The Dietary Inflammation Index (DII), measures diet-related impacts on chronic inflammation. Importantly, higher DII scores imply elevated systemic inflammation, which correlates with increased cardiovascular disease and colorectal cancer risk. The researchers used data from 190 participants in the AusLong Study, all later diagnosed with MS. Participants completed a food frequency questionnaire, from which DII scores were computed. Importantly, for each one-unit DII increase, relapse risk rose by 18%. Strikingly, those in the highest energy-adjusted scores quartile were 2.24 times more likely to relapse. […]

A phase 3, multicenter, double-blind, randomized, placebo-controlled trial was conducted to evaluate the efficacy and safety of epicutaneous immunotherapy with a peanut patch in children aged 1 to 3 years with peanut allergy. No approved treatment for peanut allergy exists for children under 4 years old. Participants with confirmed peanut allergy were assigned to either receive the peanut patch or a placebo daily for 12 months. The primary endpoint was the treatment response measured by the eliciting dose of peanut protein at 12 months. The trial showed that 67.0% of children in the intervention group demonstrated a treatment response compared to 33.5% in the placebo group. Adverse events occurred in both groups, with serious adverse events and anaphylaxis observed more frequently in the intervention group. However, serious treatment-related adverse events were rare. In conclusion, this trial demonstrated that epicutaneous immunotherapy with a peanut patch for 12 months was more effective than placebo in desensitizing children aged 1 to 3 years with peanut allergy and increasing their tolerance to peanut protein. Although adverse events were observed in both groups, serious treatment-related adverse events were uncommon. These findings suggest that epicutaneous immunotherapy may be a potential treatment option for young children with […]

Nutritional challenges are common in older adults with acute leukemia (AML/MDS), and can have a significant impact on their quality of life and treatment outcomes. These challenges can be caused by a variety of factors, including the disease itself, its treatment, and the normal aging process. Some of the most common nutritional challenges in older adults with AML/MDS include appetite loss, weight loss, diarrhea, constipation, and mouth sores; physicians can provide nutritional interventions to help address these challenges and improve the quality of life for older adults with AML/MDS. These interventions may include nutrition counseling, meal planning, supplementation, and enteral nutrition.